Top Abstract Purchase Related
Home
>
Node
>
Subnode

The use of sumatriptan in the treatment of migraine

Gross, M.

British Journal of Clinical Practice 47(4): 205-207

1993

ISSN/ISBN: 0007-0947
PMID: 8260340
Document Number: 411495
Sumatriptan is a selective agonist of 5-hydroxytryptamine receptors, recommended for the acute treatment of migraine. The 5-HT1 receptor subtype is found in the cranial vasculature of many species including humans, and causes vasoconstriction of these vessels. Sumatriptan as a highly potent 5-HT1 agonist selectively constricts large intracranial blood vessels and also blocks neurogenic inflammation. Those treating patients with severe or inconveniently timed attacks will find sumatriptan the drug of choice.

Document emailed within 1 workday
Secure & encrypted payments

Pini, L.A.; Fabbri, L.; Cavazzuti, L. 1999: Efficacy and safety of sumatriptan 50 mg in patients not responding to standard care, in the treatment of mild to moderate migraine. the Sumatriptan 50 mg Italian Study Group International Journal of Clinical Pharmacology Research 19(2): 57-64
Salonen, R.; Ashford, E.A.; Gibbs, M.; Hassani, H. 1999: Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study. Sumatriptan Tablets S2CM11 Study Group International Journal of Clinical Practice. Supplement 105: 16-24
Savani, N.; Brautaset, N.J.; Reunanen, M.; Szirmai, I.; Ashford, E.A.; Hassani, H.; Saiers, J. 1999: A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group International Journal of Clinical Practice. Suppl 105: 7-15
Pfaffenrath, V. 1993: Treatment of migraine attacks with sumatriptan Fortschritte der Medizin 111(29): 465-468
Prusiński, A. 1992: Sumatriptan and its use in treatment of migraine and cluster headaches Neurologia i Neurochirurgia Polska Suppl 2: 28-48
Láinez, J.M.; Monzón, M.J. 1995: Sumatriptan ++ in the treatment of migraine and cluster headache Revista de Neurologia 23(Suppl 2): S166-S178
Kwasa, T.O.; Jowi, J.O.; Amayo, E.O. 1995: Efficacy and tolerability of oral sumatriptan in the treatment of acute migraine East African Medical Journal 72(8): 479-482
Tepper, S.J.; Cochran, A.; Hobbs, S.; Woessner, M. 1998: Sumatriptan suppositories for the acute treatment of migraine. S2B351 Study Group International Journal of Clinical Practice 52(1): 31-35
Thomson, A.N.; Arthur, G.P.; Bergin, P.S.; Pollock, M.; Parkin, P.J.; Flanagan, M.; Samson, S.A. 1993: Subcutaneous sumatriptan in acute treatment of migraine: a multicentre New Zealand trial New Zealand Medical Journal 106(955): 171-173
Prusiński, A.; Domzał, T.; Fryze, C.; Szczudlik, A.; Barliński, J. 1995: -The evaluation of the effectiveness and tolerance of sumatriptan in abortive treatment of migraine attacks (open multicenter trial) Neurologia i Neurochirurgia Polska 29(6): 835-844
Russell, M.B.; Holm-Thomsen, O.E.; Nielsen, M.R.; Cleal, A.; Pilgrim, A.J.; Olesen, J. 1995: Sumatriptan treatment of migraine in general practice. a randomized, double-blind, placebo-controlled cross-over study Ugeskrift for Laeger 157(16): 2320-2323
Tfelt-Hansen, P. 2000: The effectiveness of combined oral lysine acetylsalicylate and metoclopramide (Migpriv) in the treatment of migraine attacks. Comparison with placebo and oral sumatriptan Functional Neurology 15(Suppl 3): 196-201
Joish, V.N.; Cady, P.S. 2001: Effect of sumatriptan on health care resource use among patients with migraine Managed Care Interface 14(1): 68-72
Boureau, F.; Kappos, L.; Schoenen, J.; Esperanca, P.; Ashford, E. 2000: A clinical comparison of sumatriptan nasal spray and dihydroergotamine nasal spray in the acute treatment of migraine International Journal of Clinical Practice 54(5): 281-286
Centonze, V.; Polito, M.B.; Di Bari, M.; Fabbri, L.; Cassiano, M.A.; Bassi, A.; Albano, O. 1995: Evaluation of the efficacy of oral sumatriptan in the management of migraine attacks. Clinical results La Clinica Terapeutica 146(11): 721-728
Kreutzkamp, B. 2007: Acute migraine. Sumatriptan-naproxen combination tablets work better than a single substance Medizinische Monatsschrift für Pharmazeuten 30(9): 348-349
Padma, M.V.; Jain, S.; Maheshwari, M.C.; Misra, S.; Karak, B.; Singh, A.K.; Meena, A.K.; Katiyar, C.K.; Tiwari, P. 1998: Efficacy and tolerability of oral sumatriptan in Indian patients with acute migraine : a multicentre study Neurology India 46(2): 105-108
Shimizu, T.; Suzuki, N. 2008: Recent topics on migraine: issues of the current treatments and new drugs for the treatment of migraine Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 131(3): 210-214
Sjaastad, O.; Bovim, G.; Stovner, L.J. 1992: Laterality of pain and other migraine criteria in common migraine. a comparison with cervicogenic headache Functional Neurology 7(4): 289-294
Castillo, J.; Martínez, F.; Corredera, E.; Lema, M.; Noya, M. 1995: Migraine and histamine: determining histidine in plasma and cerebrospinal fluid during migraine attacks Revista de Neurologia 23(122): 749-751